Skip to search.
 TSX Up 0.65% TSX Ventures Down 0.16%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
1.20 Up 0.01(0.84%) 4:00PM EDT
|After Hours : 1.17 Down 0.03 (2.50%) 5:53PM EDT
Add to Portfolio
Prev Close:1.19
Open:1.21
Bid:1.17 x 300
Ask:1.20 x 100
1y Target Est:5.67
Beta:4.17
Earnings Date:May 11 - May 15 (Est.)
Day's Range:1.17 - 1.22
52wk Range:0.36 - 2.88
Volume:1,468,625
Avg Vol (3m):4,362,980
Market Cap:129.82M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTXUp 0.84%129.82M
ASTM 0.00%N/A
BAXUp 0.31%37.31B
OSIRDown 0.23%606.31M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.94
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.27
Quarterly EPS Est (Mar-15) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback